Astrana Health, Inc.
ASTHNasdaq
$44.94
↓ -0.4%Jul 17 close · end-of-day
Price
1Y↑ +77.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$2.2B
Enterprise Value
$2.8B
P/E
73.7
P/S
0.6
P/B
2.8
EV/EBITDA
19.6
PEG
—
FCF Yield
7.0%
Dividend Yield
—
Revenue (TTM)
$3.5B
Net Income (TTM)
$30.2M
Free Cash Flow (TTM)
$155.0M
Gross Margin
—
Operating Margin
2.5%
Net Margin
0.9%
ROE
3.8%
ROIC
4.0%
Debt / Equity
1.3
Net Cash
-$549.2M
Return 1Y
+82.0%
Company profile
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. It is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1994 and is headquartered in Alhambra, California.
- CEO
- Brandon K. Sim
- Sector
- Services
- Industry
- Business Services
- Employees
- 1,900
- Headquarters
- California
- Website
- apollomed.net
Management & directors
- Sim BrandonCEO and President
- Basho ChandanCOO and CFO
- Sim Kenneth T.Executive Chairman
- Kumar Dinesh M.Chief Medical Officer
- Sobotka GlennChief Accounting Officer
Roles derived from SEC Form 4 filings.
Earnings
ASTH Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$965.1M↑ +55.6%
Diluted EPS$0.29↑ +107.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $687.2M | $773.9M | $1.1B | $1.4B | $2.0B | $3.2B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $80.5M | $98.2M | $104.3M | $84.6M | $89.3M | $78.5M |
| Net income | $37.7M | $68.9M | $45.2M | $60.7M | $43.1M | $22.5M |
| Diluted EPS | $1.01 | $1.52 | $0.99 | $1.29 | $0.90 | $0.46 |
| Operating cash flow | $46.2M | $70.3M | $82.1M | $68.2M | $52.2M | $114.6M |
| Free cash flow | $45.0M | $51.1M | $59.2M | $39.7M | $44.2M | $104.5M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 11.7% | 12.7% | 9.1% | 6.1% | 4.4% | 2.5% |
| Net margin | 5.5% | 8.9% | 3.9% | 4.4% | 2.1% | 0.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $486.3M | $478.7M | $665.2M | $620.4M | $654.8M | $956.0M | $950.5M | $965.1M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $30.1M | $28.4M | $720,000.00 | $20.6M | $20.3M | $19.2M | $18.4M | $28.5M |
| Net income | $19.2M | $16.1M | -$7.0M | $6.7M | $9.4M | $373,000.00 | $6.0M | $14.4M |
| Diluted EPS | $0.40 | $0.33 | -$0.14 | $0.14 | $0.19 | $0.01 | $0.12 | $0.29 |
| Operating cash flow | $23.2M | $34.0M | -$10.9M | $16.6M | $90.9M | $10.0M | -$2.9M | $68.1M |
| Free cash flow | $20.4M | $31.7M | -$13.5M | $13.6M | $89.5M | $7.4M | -$6.0M | $64.1M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 6.2% | 5.9% | 0.1% | 3.3% | 3.1% | 2.0% | 1.9% | 3.0% |
| Net margin | 3.9% | 3.4% | -1.0% | 1.1% | 1.4% | 0.0% | 0.6% | 1.5% |
Company news
Jul 16, 2026
Jul 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-27 | Sim Brandon· CEO and President | Tax withholding | 1,093 | $44.51 | $48,649.43 | filing |
| 2026-06-10 | Schmidt David | Award | 4,525 | $0.00 | $0.00 | filing |
| 2026-06-10 | Mazdyasni Matthew | Award | 4,525 | $0.00 | $0.00 | filing |
| 2026-06-10 | Kitayama Mitchell W | Award | 4,991 | $0.00 | $0.00 | filing |
| 2026-06-10 | Marsh Linda | Award | 4,525 | $0.00 | $0.00 | filing |
| 2026-06-10 | Dai, Weili | Award | 4,525 | $0.00 | $0.00 | filing |
| 2026-06-10 | Chiang John | Award | 4,525 | $0.00 | $0.00 | filing |
| 2026-05-16 | Basho Chandan· COO and CFO | Tax withholding | 8,155 | $38.26 | $312,010.30 | filing |
| 2026-04-14 | Basho Chandan· COO and CFO | Tax withholding | 3,870 | $29.07 | $112,500.90 | filing |
| 2026-04-06 | Lam Thomas S. | Award | 41,667 | $0.00 | $0.00 | filing |
| 2026-04-06 | Sim Kenneth T.· Executive Chairman | Award | 100,000 | $0.00 | $0.00 | filing |
| 2026-04-06 | Sim Brandon· CEO and President | Award | 201,056 | $0.00 | $0.00 | filing |
| 2026-04-02 | Basho Chandan· COO and CFO | Tax withholding | 2,092 | $25.05 | $52,404.60 | filing |
| 2026-04-01 | Kumar Dinesh M.· Chief Medical Officer | Tax withholding | 57,980 | $24.51 | $1.4M | filing |
| 2026-04-01 | Kumar Dinesh M.· Chief Medical Officer | Award | 35,300 | $0.00 | $0.00 | filing |
| 2026-03-26 | Sobotka Glenn· Chief Accounting Officer | Tax withholding | 662 | $24.27 | $16,066.74 | filing |
| 2026-03-05 | Lam Thomas S. | Tax withholding | 9,266 | $25.07 | $232,298.62 | filing |
| 2026-03-05 | Kumar Dinesh M.· Chief Medical Officer | Tax withholding | 1,697 | $25.07 | $42,543.79 | filing |
| 2026-03-05 | Basho Chandan· COO and CFO | Tax withholding | 1,240 | $25.07 | $31,086.80 | filing |
| 2026-02-02 | Sim Brandon· CEO and President | Option exercise | 21,334 | $23.24 | $495,802.16 | filing |
| 2026-01-23 | Kumar Dinesh M.· Chief Medical Officer | Tax withholding | 10,759 | $27.16 | $292,214.44 | filing |
| 2026-01-13 | Schmidt David | Option exercise | 20,000 | $5.79 | $115,800.00 | filing |
| 2026-01-13 | Schmidt David | Tax withholding | 4,269 | $27.12 | $115,775.28 | filing |
| 2026-01-01 | Kumar Dinesh M.· Chief Medical Officer | Tax withholding | 5,102 | $24.81 | $126,580.62 | filing |
| 2025-12-08 | Lam Thomas S. | Tax withholding | 25,866 | $22.00 | $569,052.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.